Thalassemia, Beta

9 registered clinical trials studyying Thalassemia, Beta — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Long-term Follow-up Study of BRL-101 for TDT NCT06298630	Bioray Laboratories	—
Completed	Impact of Virtual Reality on Pain and Anxiety During Intravenous Cannulation Procedures Among Thalassemia Pati NCT07099196	Mohammed Bin Rashid University of Medicine and Health Sciences	N/A
Recruiting	Safety and Efficacy Evaluation of Autologous CRISPR-Cas12b Edited Hematopoietic Stem Cells NCT06041620	Institute of Hematology & Blood Diseases Hospital, China	N/A
Recruiting	A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to NCT05736419	Memorial Sloan Kettering Cancer Center	Phase 2
Recruiting	Long-term Follow-up Study of BHC001 for TDT NCT06314529	Bioray Laboratories	—
Recruiting	Study of the Role of Genetic Modifiers in Hemoglobinopathies NCT05799118	Cyprus Institute of Neurology and Genetics	—
Completed	Thalidomide and Hydroxyurea Combination in β-Thalassemia Patients NCT06153784	Children's Hospital Karachi	Phase 2 / Phase 3
Completed	Clinical Experience of Thalidomide in Thalassemic Patients NCT05132270	Children's Hospital Karachi	Phase 2 / Phase 3
Unknown	The Efficacy and Safety of HYDROXYUREA in Management of Beta Thalassemia Patients in Karachi Pakistan NCT03183375	Dr.Saqib Hussain Ansari	Phase 2